Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barry M Brenner

Showing results (11-20 of 70) with videos related to

Pageof 7
Sort By:
Current Opinion in Nephrology and Hypertension|July 10, 2002
Combination ACEI and ARB therapy: additional benefit in renoprotection?Maarten W Taal, Barry M Brenner
Journal of Hypertension|September 9, 2005
Primary and secondary prevention of chronic kidney diseaseKambiz Zandi-Nejad, Barry M Brenner
The New England Journal of Medicine|February 25, 2005
Preventing microalbuminuria in type 2 diabetesKambiz Zandi-Nejad, Barry M Brenner
Current Opinion in Nephrology and Hypertension|December 20, 2007
Defining renal riskMaarten W Taal, Barry M Brenner
Anatomical Record (Hoboken, N.J. : 2007)|October 7, 2019
Clinical consequences of developmental programming of low nephron numberValerie A Luyckx, Barry M Brenner
Journal of the American Society of Nephrology : JASN|February 13, 2010
The clinical importance of nephron massValerie A Luyckx, Barry M Brenner
The Medical Clinics of North America|March 10, 2005
Strategies to retard the progression of chronic kidney diseaseKambiz Zandi-Nejad, Barry M Brenner
Nature Reviews. Nephrology|January 21, 2015
Birth weight, malnutrition and kidney-associated outcomes--a global concernValerie A Luyckx, Barry M Brenner
Kidney International|December 1, 2004
From secondary to primary prevention of progressive renal disease: the case for screening for albuminuriaPaul E de Jong, Barry M Brenner
Rambam Maimonides Medical Journal|August 3, 2013
Low nephron number and its clinical consequencesValerie A Luyckx, Khuloud Shukha, Barry M Brenner
Pageof 7

Showing results (11-20 of 70) with videos related to

Sort By:
Pageof 7
Current Opinion in Nephrology and Hypertension|July 10, 2002
Combination ACEI and ARB therapy: additional benefit in renoprotection?Maarten W Taal, Barry M Brenner
Journal of Hypertension|September 9, 2005
Primary and secondary prevention of chronic kidney diseaseKambiz Zandi-Nejad, Barry M Brenner
The New England Journal of Medicine|February 25, 2005
Preventing microalbuminuria in type 2 diabetesKambiz Zandi-Nejad, Barry M Brenner
Current Opinion in Nephrology and Hypertension|December 20, 2007
Defining renal riskMaarten W Taal, Barry M Brenner
Anatomical Record (Hoboken, N.J. : 2007)|October 7, 2019
Clinical consequences of developmental programming of low nephron numberValerie A Luyckx, Barry M Brenner
Journal of the American Society of Nephrology : JASN|February 13, 2010
The clinical importance of nephron massValerie A Luyckx, Barry M Brenner
The Medical Clinics of North America|March 10, 2005
Strategies to retard the progression of chronic kidney diseaseKambiz Zandi-Nejad, Barry M Brenner
Nature Reviews. Nephrology|January 21, 2015
Birth weight, malnutrition and kidney-associated outcomes--a global concernValerie A Luyckx, Barry M Brenner
Kidney International|December 1, 2004
From secondary to primary prevention of progressive renal disease: the case for screening for albuminuriaPaul E de Jong, Barry M Brenner
Rambam Maimonides Medical Journal|August 3, 2013
Low nephron number and its clinical consequencesValerie A Luyckx, Khuloud Shukha, Barry M Brenner
Pageof 7